These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22914311)

  • 1. Allergen-specific immunotherapy and risk of autoimmune disease.
    Linneberg A; Madsen F; Skaaby T
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):635-9. PubMed ID: 22914311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immunmodulators in allergen-specific immunotherapy.
    Kopp MV
    Allergy; 2011 Jun; 66(6):792-7. PubMed ID: 21332502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship?
    Asero R; Farioli L; Pastorello EA
    Int Arch Allergy Immunol; 2012; 158(3):276-80. PubMed ID: 22398453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children.
    Majak P; Jerzyńska J; Smejda K; Stelmach I; Timler D; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Nov; 109(5):329-35. PubMed ID: 23062388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality.
    Linneberg A; Jacobsen RK; Jespersen L; Abildstrøm SZ
    J Allergy Clin Immunol; 2012 Feb; 129(2):413-9. PubMed ID: 22004944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
    Maazi H; Shirinbak S; Willart M; Hammad HM; Cabanski M; Boon L; Ganesh V; Baru AM; Hansen G; Lambrecht BN; Sparwasser T; Nawijn MC; van Oosterhout AJ
    Clin Exp Allergy; 2012 Oct; 42(10):1519-28. PubMed ID: 22994349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.
    Moreno C; Cuesta-Herranz J; Fernández-Távora L; Alvarez-Cuesta E;
    Clin Exp Allergy; 2004 Apr; 34(4):527-31. PubMed ID: 15080803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?
    Senti G; von Moos S; Kündig TM
    Allergy; 2011 Jun; 66(6):798-809. PubMed ID: 21518374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
    Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergen-specific immune therapy in the treatment of asthma].
    Malling HJ
    Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of sino-nasal polyposis by Candida albicans immunotherapy: apropos of 4 cases].
    Bénoliel P
    Allerg Immunol (Paris); 2001 Dec; 33(10):388-94. PubMed ID: 11802479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health economics of allergen immunotherapy.
    Hankin CS; Cox L; Bronstone A
    Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.